Articles de revues sur le sujet « Hypothalmic diseases »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Hypothalmic diseases ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Haug, R. H. "Recovery of the hypothalmic-pituitary adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone." Journal of Oral and Maxillofacial Surgery 52, no. 2 (1994): 203. http://dx.doi.org/10.1016/0278-2391(94)90422-7.
Texte intégralKim, Ye Jin, Thai Hien Tu, Sunggu Yang, Jae Kwang Kim, and Jae Geun Kim. "Characterization of Fatty Acid Composition Underlying Hypothalamic Inflammation in Aged Mice." Molecules 25, no. 14 (2020): 3170. http://dx.doi.org/10.3390/molecules25143170.
Texte intégralZapanti, Evangelia, Konstantinos Terzidis, and George Chrousos. "Dysfunction of the Hypothalamic-Pituitary-Adrenal axis in HIV infection and disease." HORMONES 7, no. 3 (2008): 205–16. http://dx.doi.org/10.14310/horm.2002.1200.
Texte intégralMravec, Boris, and Alena Szelle Černáčková. "Hypothalamic inflammation and somatic diseases." Česká a slovenská neurologie a neurochirurgie 81/114, no. 3 (2018): 278–83. http://dx.doi.org/10.14735/amcsnn2018278.
Texte intégralvon Werder, K., and O. A. Müller. "Medical therapy of hypothalamic diseases." Acta Neurochirurgica 75, no. 1-4 (1985): 147–51. http://dx.doi.org/10.1007/bf01406335.
Texte intégralSalvio, Gianmaria, Marianna Martino, Giulia Giancola, Giorgio Arnaldi, and Giancarlo Balercia. "Hypothalamic–Pituitary Diseases and Erectile Dysfunction." Journal of Clinical Medicine 10, no. 12 (2021): 2551. http://dx.doi.org/10.3390/jcm10122551.
Texte intégralSwaab, Dick F. "Hypothalamic Peptides in Human Brain Diseases." Trends in Endocrinology & Metabolism 10, no. 6 (1999): 236–44. http://dx.doi.org/10.1016/s1043-2760(99)00158-7.
Texte intégralReimann, Hobart A. "HYPOTHALAMIC-HYPOPHYSEAL-NEURAL INFLUENCE IN PERIODIC DISEASES." Annals of the New York Academy of Sciences 117, no. 1 (2006): 589–94. http://dx.doi.org/10.1111/j.1749-6632.1964.tb48210.x.
Texte intégralLapko, Inna V., Alla V. Zheglova, Kristina V. Klimkina, and Inessa A. Bogatyreva. "Neurohumoral regulation under exposure to vibration and physical overloads." Hygiene and sanitation 101, no. 10 (2022): 1200–1205. http://dx.doi.org/10.47470/0016-9900-2022-101-10-1200-1205.
Texte intégralStathori, Galateia, Kyriaki Hatziagapiou, George Mastorakos, Nikolaos F. Vlahos, Evangelia Charmandari, and Georgios Valsamakis. "Endocrine-Disrupting Chemicals, Hypothalamic Inflammation and Reproductive Outcomes: A Review of the Literature." International Journal of Molecular Sciences 25, no. 21 (2024): 11344. http://dx.doi.org/10.3390/ijms252111344.
Texte intégralMravec, Boris, Lubica Horvathova, and Alena Cernackova. "Hypothalamic Inflammation at a Crossroad of Somatic Diseases." Cellular and Molecular Neurobiology 39, no. 1 (2018): 11–29. http://dx.doi.org/10.1007/s10571-018-0631-4.
Texte intégralCai, Dongsheng, and Sinan Khor. "“Hypothalamic Microinflammation” Paradigm in Aging and Metabolic Diseases." Cell Metabolism 30, no. 1 (2019): 19–35. http://dx.doi.org/10.1016/j.cmet.2019.05.021.
Texte intégralKaragiannis, Asterios, and Faidon Harsoulis. "Gonadal dysfunction in systemic diseases." European Journal of Endocrinology 152, no. 4 (2005): 501–13. http://dx.doi.org/10.1530/eje.1.01886.
Texte intégralRychlik, A., M. Nowicki, A. Kolodziejska-Sawerska, and M. Szweda. "The effect of orally administered Budesonide on the hypothalamic-pituitary-adrenal axis in dogs with inflammatory bowel disease." Veterinární Medicína 62, No. 5 (2017): 261–68. http://dx.doi.org/10.17221/130/2015-vetmed.
Texte intégralPlakkot, Bhuvana, Ashley Di Agostino, and Madhan Subramanian. "Implications of Hypothalamic Neural Stem Cells on Aging and Obesity-Associated Cardiovascular Diseases." Cells 12, no. 5 (2023): 769. http://dx.doi.org/10.3390/cells12050769.
Texte intégralCai, Dongsheng, and Tiewen Liu. "Hypothalamic inflammation: a double-edged sword to nutritional diseases." Annals of the New York Academy of Sciences 1243, no. 1 (2011): E1—E39. http://dx.doi.org/10.1111/j.1749-6632.2011.06388.x.
Texte intégralDjordjevic, Ana, Nataša Veličković, Biljana Bursać, Ana Teofilović, and Gordana Matić. "The role of glucocorticoid hormones in diet-induced metabolic diseases." Biologia Serbica 39, no. 1 (2017): 16–25. https://doi.org/10.5281/zenodo.826607.
Texte intégralKurup, R. K., and P. A. Kurup. "Hypothalamic digoxin and brain function." Acta Neuropsychiatrica 15, no. 2 (2003): 74–90. http://dx.doi.org/10.1034/j.1601-5215.2003.00012.x.
Texte intégralMüller, Hermann L. "RARE-04. Hypothalamic syndrome – severe sequelae due to different sellar and parasellar masses." Neuro-Oncology 24, Supplement_1 (2022): i9—i10. http://dx.doi.org/10.1093/neuonc/noac079.029.
Texte intégralKURUP, RAVI KUMAR, and PARAMESWARA ACHUTHA KURUP. "HYPOTHALAMIC DIGOXIN, CEREBRAL CHEMICAL DOMINANCE, AND PATHOGENESIS OF PULMONARY DISEASES." International Journal of Neuroscience 113, no. 2 (2003): 235–58. http://dx.doi.org/10.1080/00207450390162056.
Texte intégralABRAMSKY, O., E. WERTMAN, A. RECHES, T. BRENNER, and H. OVADIA. "Effect of Hypothalamic Lesions on Experimental Autoimmune Diseases in Rats." Annals of the New York Academy of Sciences 496, no. 1 Neuroimmune I (1987): 360–65. http://dx.doi.org/10.1111/j.1749-6632.1987.tb35788.x.
Texte intégralUlisse, Salvatore, Enke Baldini, Daniele Pironi, et al. "Is Melanoma Progression Affected by Thyroid Diseases?" International Journal of Molecular Sciences 23, no. 17 (2022): 10036. http://dx.doi.org/10.3390/ijms231710036.
Texte intégralThomaz, Natalie K., Larissa Daniele Bobermin, and André Quincozes-Santos. "Sexual Dimorphism and Hypothalamic Astrocytes: Focus on Glioprotection." Neuroglia 5, no. 3 (2024): 274–88. http://dx.doi.org/10.3390/neuroglia5030019.
Texte intégralMelnichenko, G. A., V. A. Chernogolov, and M. G. Pavlova. "General data on the hypothalamic-pituitary disorders (guidelines for patients)." Problems of Endocrinology 42, no. 4 (1996): 31–32. http://dx.doi.org/10.14341/probl12072.
Texte intégralNoraliev, I.A. "THE ROLE OF DEPRESSION IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASES." Multidisciplinary Journal of Science and Technology 5, no. 5 (2025): 830–32. https://doi.org/10.5281/zenodo.15465028.
Texte intégralMukhopadhyay, Debasmita, and Bashair M. Mussa. "Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis." Brain Sciences 10, no. 10 (2020): 666. http://dx.doi.org/10.3390/brainsci10100666.
Texte intégralVorontsov, A. V., T. V. Semicheva, and V. A. Peterkova. "Magnetic resonance imaging in the diagnosis of hypothalamopituitary diseases in patients with true premature sexual development." Problems of Endocrinology 49, no. 1 (2003): 32–36. http://dx.doi.org/10.14341/probl11438.
Texte intégralSchaefer, S., N. Boegershausen, S. Meyer, D. Ivan, K. Schepelmann, and P. H. Kann. "Hypothalamic–pituitary insufficiency following infectious diseases of the central nervous system." European Journal of Endocrinology 158, no. 1 (2008): 3–9. http://dx.doi.org/10.1530/eje-07-0484.
Texte intégralCrofford, Leslie J. "The hypothalamic–pituitary–adrenal axis in the pathogenesis of rheumatic diseases." Endocrinology and Metabolism Clinics of North America 31, no. 1 (2002): 1–13. http://dx.doi.org/10.1016/s0889-8529(01)00004-4.
Texte intégralHARBUZ, M. S., D. S. JESSOP, H. S. CHOWDREY, J. M. BLACKWELL, P. J. LARSEN, and S. L. LIGHTMAN. "Evidence for Altered Control of Hypothalamic CRF in Immune-Mediated Diseases." Annals of the New York Academy of Sciences 771, no. 1 Stress (1995): 449–58. http://dx.doi.org/10.1111/j.1749-6632.1995.tb44701.x.
Texte intégralLee, Hannah, Thai Hien Tu, Byong Seo Park, Sunggu Yang, and Jae Geun Kim. "Adiponectin Reverses the Hypothalamic Microglial Inflammation during Short-Term Exposure to Fat-Rich Diet." International Journal of Molecular Sciences 20, no. 22 (2019): 5738. http://dx.doi.org/10.3390/ijms20225738.
Texte intégralLencu, Codruţa, Teodora Alexescu, Mirela Petrulea, and Monica Lencu. "RESPIRATORY MANIFESTATIONS IN ENDOCRINE DISEASES." Medicine and Pharmacy Reports 89, no. 4 (2016): 459–63. http://dx.doi.org/10.15386/cjmed-671.
Texte intégralKõks, Sulev, Ursel Soomets, Mario Plaas, et al. "Hypothalamic gene expression profile indicates a reduction in G protein signaling in the Wfs1 mutant mice." Physiological Genomics 43, no. 24 (2011): 1351–58. http://dx.doi.org/10.1152/physiolgenomics.00117.2011.
Texte intégralRyzhov, J. R., and A. O. Shpakov. "ADIPONECTIN AS AN ENDOGENOUS REGULATOR OF THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS." Translational Medicine 5, no. 5 (2018): 26–36. http://dx.doi.org/10.18705/2311-4495-2018-5-5-.
Texte intégralRyzhov, J. R., and A. O. Shpakov. "ADIPONECTIN AS AN ENDOGENOUS REGULATOR OF THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS." Translational Medicine 5, no. 5 (2018): 26–36. http://dx.doi.org/10.18705/2311-4495-2018-5-5-26-36.
Texte intégralPark, Joon Seok, Kyu Sik Kim, and Hyung Jin Choi. "Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies." Diabetes & Metabolism Journal 49, no. 3 (2025): 333–47. https://doi.org/10.4093/dmj.2025.0106.
Texte intégralVan Drunen, Rachel, and Kristin Eckel-Mahan. "Circadian Rhythms of the Hypothalamus: From Function to Physiology." Clocks & Sleep 3, no. 1 (2021): 189–226. http://dx.doi.org/10.3390/clockssleep3010012.
Texte intégralHosseinifard, Elaheh-Sadat, Khadijeh Bavafa-Valenlia, Maryam Saghafi-Asl, and Mohammad Morshedi. "Antioxidative and Metabolic Effects of Lactobacillus plantarum, Inulin, and Their Synbiotic on the Hypothalamus and Serum of Healthy Rats." Nutrition and Metabolic Insights 13 (January 2020): 117863882092509. http://dx.doi.org/10.1177/1178638820925092.
Texte intégralLaviano, Alessandro, Akio Inui, Daniel L. Marks, et al. "Neural control of the anorexia-cachexia syndrome." American Journal of Physiology-Endocrinology and Metabolism 295, no. 5 (2008): E1000—E1008. http://dx.doi.org/10.1152/ajpendo.90252.2008.
Texte intégralPanaro, Maria Antonietta, Tarek Benameur, and Chiara Porro. "Hypothalamic Neuropeptide Brain Protection: Focus on Oxytocin." Journal of Clinical Medicine 9, no. 5 (2020): 1534. http://dx.doi.org/10.3390/jcm9051534.
Texte intégralChiurazzi, Martina, Martina Di Maro, Mauro Cozzolino, and Antonio Colantuoni. "Mitochondrial Dynamics and Microglia as New Targets in Metabolism Regulation." International Journal of Molecular Sciences 21, no. 10 (2020): 3450. http://dx.doi.org/10.3390/ijms21103450.
Texte intégralKAUPPILA, MARJUT, PERTTI KOSKINEN, KARI REMES, JORMA VIIKARI та KERTTU IRJALA. "Hypothalamic-Pituitary Axis Remains Intact After Interferon-α Treatment in Hematologic Diseases". Journal of Interferon & Cytokine Research 17, № 9 (1997): 543–50. http://dx.doi.org/10.1089/jir.1997.17.543.
Texte intégralSabirova, E. Y., and E. N. Anisimova. "AGING AND CIRCADIAN RHYTHM DISORDERS: CURRENT STATE OF THE ISSUE." DRUGS AND RATIONAL PHARMACOTHERAPY 11, no. 2 (2024): 32–36. http://dx.doi.org/10.56356/27827259_2023_11_32.
Texte intégralSalahuddin, Mohammed F., Fakhri Mahdi, Suresh P. Sulochana, and Jason J. Paris. "HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone’s Psychomotor Effects in Female Mice." Viruses 13, no. 5 (2021): 813. http://dx.doi.org/10.3390/v13050813.
Texte intégralZenkova, T. S., and I. A. Fedin. "The use of magnetic resonance imaging in the diagnosis of diseases of the hypothalamic-pituitary system." Problems of Endocrinology 39, no. 6 (1993): 57–62. http://dx.doi.org/10.14341/probl11955.
Texte intégralMolfino, Alessio, Gianfranco Gioia, Filippo Rossi Fanelli, and Alessandro Laviano. "Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia." Mediators of Inflammation 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/801685.
Texte intégralGilyazutdinov, I. A., M. K. Mikhailov, and F. Z. Mindubaeva. "Importance of craniography in the diagnosis of neuroendocrinal syndromes and central genesis diseases." Kazan medical journal 74, no. 4 (1993): 288–90. http://dx.doi.org/10.17816/kazmj71446.
Texte intégralMakovka, Yu V., L. A. Fedoseeva, D. Yu Oshchepkov, A. L. Markel, and O. E. Redina. "Restraint stress-induced expression of <i>Fos</i> and several related genes in the hypothalamus of the hypertensive ISIAH rats." Молекулярная биология 58, no. 1 (2024): 78–87. http://dx.doi.org/10.31857/s0026898424010079.
Texte intégralPigarova, E. A., L. K. Dzeranova, and L. Ya Rozhinskaya. "Klinicheskiy sluchay narusheniyavodno-elektrolitnogo obmena kak pervogosimptoma rasprostranennogo metastaticheskogoprotsessa: osobennosti diagnostiki i lecheniyapreparatom sinteticheskogo analogavazopressina (Presayneks)." Obesity and metabolism 8, no. 3 (2011): 67–70. http://dx.doi.org/10.14341/2071-8713-4840.
Texte intégralMuir, Andrew, and Noel K. Maclaren. "Autoimmune Diseases of the Adrenal Glands, Parathyroid Glands, Gonads, and Hypothalamic-Pituitary Axis." Endocrinology and Metabolism Clinics of North America 20, no. 3 (1991): 619–44. http://dx.doi.org/10.1016/s0889-8529(18)30261-5.
Texte intégral